Document Detail


Home uterine activity monitoring: the role of medical evidence.
MedLine Citation:
PMID:  18669730     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The current paradigm in obstetrics has shifted toward evidence-based medicine, and yet in clinical practice physicians continue to use interventions for which there exists no credible evidence. This article examines the U.S. Food and Drug Administration (FDA) status of home uterine activity monitoring (HUAM) and the published clinical trials examining HUAM for the management of current preterm labor. The use of HUAM was introduced into clinical practice and heavily marketed without benefit of scientific rigor. Gradually, HUAM use migrated primarily for patients diagnosed (or misdiagnosed) with preterm labor in the current pregnancy who are stabilized and sent home with or without a tocolytic. This clinical intervention has not been cleared by the FDA, has virtually no scientific support, and constitutes a gross deviation from evidence-based medicine. As obstetricians accept the role of medical evidence steering clinical practice, HUAM clearly has no clinical value and therefore should not be used to manage patients outside of a randomized controlled clinical trial.
Authors:
James P Reichmann
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Obstetrics and gynecology     Volume:  112     ISSN:  0029-7844     ISO Abbreviation:  Obstet Gynecol     Publication Date:  2008 Aug 
Date Detail:
Created Date:  2008-08-01     Completed Date:  2008-09-16     Revised Date:  2009-10-26    
Medline Journal Info:
Nlm Unique ID:  0401101     Medline TA:  Obstet Gynecol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  325-7     Citation Subset:  AIM; IM    
Affiliation:
jim.reichmann@ahom.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Evidence-Based Medicine
Female
Humans
Monitoring, Ambulatory
Obstetric Labor, Premature / diagnosis*
Pregnancy
Randomized Controlled Trials as Topic
United States
United States Food and Drug Administration
Uterine Monitoring* / methods
Comments/Corrections
Comment In:
Obstet Gynecol. 2009 Jan;113(1):229; author reply 229   [PMID:  19104383 ]
Obstet Gynecol. 2008 Dec;112(6):1389; author reply 1389-90   [PMID:  19037050 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Inherited thrombophilia and pregnancy complications revisited.
Next Document:  Changing the paradigm in surgical education.